| Synonyms: | |
| Status: | Approved (2022) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | VHH774W97N |
| InChI Key | IDUYJRXRDSPPRC-NRFANRHFSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C23H16F7N5O2 |
| Molecular Weight | 527.4 |
| AlogP | 4.63 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 85.95 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 37.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C19
|
- | 72000 | - | - | - | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C9
|
- | 99000 | - | - | - | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | 65000-65000 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Candidiasis, Vulvovaginal | 3 | D002181 | ClinicalTrials |
| Tinea Pedis | 2 | D014008 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3311228 |
| DrugBank | DB13055 |
| FDA SRS | VHH774W97N |
| PDB | VT1 |
| PubChem | 77050711 |
| SureChEMBL | SCHEMBL17113021 |
| ZINC | ZINC000167574450 |